{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:51:15Z","timestamp":1787003475407,"version":"build-2736575974"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T00:00:00Z","timestamp":1660262400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T00:00:00Z","timestamp":1660262400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The activation of nicotinamide adenine dinucleotide (NAD\n                    <jats:sup>+<\/jats:sup>\n                    )-dependent deacetylase, Sirt1, after the administration of nicotinamide mononucleotide (NMN) suppresses many diseases. However, the role of NMN and Sirt1 in focal glomerulosclerosis (FSGS) has not yet been elucidated. This study aimed to assess the protective effect of NMN treatment in mice with adriamycin (ADR)-induced FSGS.\u3000Transient short-term NMN treatment was administered to 8-week-old ADR- or saline-treated BALB\/c mice (Cont group) for 14 consecutive days. NMN alleviated the increase in urinary albumin excretion in the ADR-treated mice. NMN treatment mitigated glomerulosclerosis and ameliorated the reduced Sirt1 expression and elevated Claudin-1 expression in the kidneys of the mice. Moreover, this treatment improved the decrease in histone methylation and the expression level of Dnmt1 and increased the concentration of NAD\n                    <jats:sup>+<\/jats:sup>\n                    in the kidney. Dnmt1 epigenetically suppressed the expression of the NMN-consuming enzyme nicotinamide mononucleotide adenyltransferase1 (Nmnat1) by methylating the E-box in the promoter region and repressing the NAD-consuming enzyme PARP1. Additionally, NMN downregulated the expression of Nmnat1 in the ADR-treated mice. Short-term NMN treatment in FSGS has epigenetic renal protective effects through the upregulation of Sirt1 and suppression of the NAD and NMN consumers. The present study presents a novel treatment paradigm for FSGS.\n                  <\/jats:p>","DOI":"10.1038\/s41598-022-18147-2","type":"journal-article","created":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T06:05:50Z","timestamp":1660284350000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Nicotinamide mononucleotide ameliorates adriamycin-induced renal damage by epigenetically suppressing the NMN\/NAD consumers mediated by Twist2"],"prefix":"10.1038","volume":"12","author":[{"given":"Kazuhiro","family":"Hasegawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Sakamaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Tamaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Wakino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,12]]},"reference":[{"key":"18147_CR1","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/j.1440-1797.2010.01383.x","volume":"16","author":"VW Lee","year":"2011","unstructured":"Lee, V. W. & Harris, D. C. Adriamycin nephropathy a model of focal segmental glomerulosclerosis. Nephrology (Carlton) 16, 30\u201338 (2011).","journal-title":"Nephrology (Carlton)"},{"issue":"12(10)","key":"18147_CR2","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/s41419-021-04156-y","volume":"27","author":"Z Lu","year":"2021","unstructured":"Lu, Z. et al. METTL14 aggravates podocyte injury and glomerulopathy progression through N6-methyladenosine-dependent downregulating of Sirt1. Cell Death Dis. 27(12(10)), 881 (2021).","journal-title":"Cell Death Dis."},{"key":"18147_CR3","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1038\/nm.3363","volume":"19","author":"K Hasegawa","year":"2013","unstructured":"Hasegawa, K. et al. Renal tubular Sirt1 attenuates diabetic albuminuria by epigenetically suppressing Claudin-1 overexpression in podocytes. Nat. Med. 19, 1496\u20131504 (2013).","journal-title":"Nat. Med."},{"issue":"15","key":"18147_CR4","doi-asserted-by":"publisher","first-page":"e0231898","DOI":"10.1371\/journal.pone.0231898","volume":"17","author":"EN Bukosza","year":"2020","unstructured":"Bukosza, E. N. et al. Podocyte RNA sequencing reveals Wnt- and ECM-associated genes as central in FSGS. PLoS\u00a0One 17(15), e0231898 (2020).","journal-title":"PLoS\u00a0One"},{"key":"18147_CR5","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1681\/ASN.2015121324","volume":"28","author":"Y Gong","year":"2017","unstructured":"Gong, Y. et al. Inducible expression of claudin-1 in glomerular podocytes generates aberrant tight junctions and proteinuria through slit diaphragm destabilization. J. Am. Soc. Nephrol. 28, 106\u2013117 (2017).","journal-title":"J. Am. Soc. Nephrol."},{"key":"18147_CR6","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","volume":"359","author":"RR Holman","year":"2008","unstructured":"Holman, R. R. et al. 10-year follow-up of intensive glucose control in type 2 diabetes. N. Engl. J. Med. 359, 1577\u20131589 (2008).","journal-title":"N. Engl. J. Med."},{"key":"18147_CR7","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.yjmcc.2018.10.001","volume":"20","author":"D Khadka","year":"2018","unstructured":"Khadka, D. et al. Augmentation of NAD levels by enzymatic action of NAD(P)H quinone oxidoreductase 1 attenuates adriamycin-induced cardiac dysfunction in mice. J. Mol. Cell Cardiol. 20, 45\u201357 (2018).","journal-title":"J. Mol. Cell Cardiol."},{"key":"18147_CR8","doi-asserted-by":"publisher","first-page":"723690","DOI":"10.3389\/fphys.2021.723690","volume":"12","author":"X Liu","year":"2021","unstructured":"Liu, X. et al. Impaired nicotinamide adenine dinucleotide biosynthesis in the kidney of chronic kidney disease. Front. Physiol. 12, 723690 (2021).","journal-title":"Front. Physiol."},{"key":"18147_CR9","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.pharmthera.2018.03.004","volume":"188","author":"H Dai","year":"2018","unstructured":"Dai, H. et al. Sirtuin activators and inhibitors: Promises, achievements, and challenges. Pharmacol. Ther. 188, 140\u2013154 (2018).","journal-title":"Pharmacol. Ther."},{"key":"18147_CR10","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1210\/js.2017-00092","volume":"1","author":"YS Elhassan","year":"2017","unstructured":"Elhassan, Y. S., Philp, A. A. & Lavery, G. G. Targeting NAD+ in metabolic disease: New insights into an old molecule. J. Endocr. Soc. 1, 816\u2013835 (2017).","journal-title":"J. Endocr. Soc."},{"key":"18147_CR11","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1172\/JCI41376","volume":"120","author":"S Kume","year":"2010","unstructured":"Kume, S. et al. Calorie restriction enhances cell adaptation to hypoxia through Sirt1-dependent mitochondrial autophagy in mouse aged kidney. J. Clin. Invest. 120, 1043\u20131055 (2010).","journal-title":"J. Clin. Invest."},{"key":"18147_CR12","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/s00125-012-2747-2","volume":"56","author":"MY Kim","year":"2013","unstructured":"Kim, M. Y. et al. Resveratrol prevents renal lipotoxicity and inhibits mesangial cell glucotoxicity in a manner dependent on the AMPK-SIRT1-PGC1\u03b1 axis in ADR mice. Diabetologia 56, 204\u2013217 (2013).","journal-title":"Diabetologia"},{"key":"18147_CR13","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.cmet.2017.11.002","volume":"27","author":"J Yoshino","year":"2018","unstructured":"Yoshino, J., Baur, J. A. & Imai, S. I. NAD+Intermediates: The biology and therapeutic potential of NMN and NR. Cell Metab. 27, 513\u2013528 (2018).","journal-title":"Cell Metab."},{"key":"18147_CR14","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.cmet.2011.03.004","volume":"13","author":"P Bai","year":"2011","unstructured":"Bai, P. et al. PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation. Cell Metab. 13, 461\u2013468 (2011).","journal-title":"Cell Metab."},{"key":"18147_CR15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1172\/JCI23626","volume":"115","author":"Z Beny\u00f3","year":"2005","unstructured":"Beny\u00f3, Z. et al. GPR109A (PUMA-G\/HM74A) mediates nicotinic acid-induced flushing. J. Clin. Invest. 115, 25 (2005).","journal-title":"J. Clin. Invest."},{"key":"18147_CR16","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1124\/mol.106.030833","volume":"70","author":"Z Beny\u00f3","year":"2006","unstructured":"Beny\u00f3, Z. et al. Nicotinic acid-induced flushing is mediated by activation of epidermal langerhans cells. Mol. Pharmacol. 70, 1844\u20131849 (2006).","journal-title":"Mol. Pharmacol."},{"key":"18147_CR17","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/S0190-9622(81)80211-3","volume":"4","author":"HS Zackheim","year":"1981","unstructured":"Zackheim, H. S. et al. Reactions to niacinamide. J. Am. Acad. Dermatol. 4, 736\u2013737 (1981).","journal-title":"J. Am. Acad. Dermatol."},{"key":"18147_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms12948","volume":"7","author":"SAAJ Trammell","year":"2016","unstructured":"Trammell, S. A. A. J. et al. Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. Nat. Commun. 7, 1\u201314 (2016).","journal-title":"Nat. Commun."},{"key":"18147_CR19","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1681\/ASN.2016040385","volume":"28","author":"Y Guan","year":"2017","unstructured":"Guan, Y. et al. Nicotinamide mononucleotide, an NAD + precursor, rescues age-associated susceptibility to AKI in a Sirtuin 1-dependent manner. J. Am. Soc. Nephrol. 28, 2337\u20132352 (2017).","journal-title":"J. Am. Soc. Nephrol."},{"key":"18147_CR20","first-page":"4181","volume":"14","author":"Y Chen","year":"2017","unstructured":"Chen, Y. et al. Endogenous nampt upregulation is associated with diabetic nephropathy inflammatory-fibrosis through the NF-\u03baB p65 and Sirt1 pathway; NMN alleviates diabetic nephropathy inflammatory-fibrosis by inhibiting endogenous Nampt. Exp. Ther. Med. 14, 4181\u20134193 (2017).","journal-title":"Exp. Ther. Med."},{"key":"18147_CR21","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1172\/jci.insight.126749","volume":"4","author":"MR Lynch","year":"2019","unstructured":"Lynch, M. R. et al. TFEB-driven lysosomal biogenesis is pivotal for PGC1\u03b1-dependent renal stress resistance. JCI Insight 4, 25 (2019).","journal-title":"JCI Insight"},{"key":"18147_CR22","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1681\/ASN.2020081188","volume":"32","author":"I Yasuda","year":"2021","unstructured":"Yasuda, I. et al. Pre-emptive short-term nicotinamide mononucleotide treatment in a mouse model of diabetic Nephropathy. J. Am. Soc. Nephrol. 32, 1355\u20131370 (2021).","journal-title":"J. Am. Soc. Nephrol."},{"key":"18147_CR23","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1046\/j.1523-1755.2000.00342.x","volume":"58","author":"Y Wang","year":"2000","unstructured":"Wang, Y. et al. Progressive adriamycin nephropathy in mice: Sequence of histologic and immunohistochemical events. Kidney Int. 58, 1797\u20131804 (2000).","journal-title":"Kidney Int."},{"key":"18147_CR24","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.celrep.2019.03.024","volume":"27","author":"H Muraoka","year":"2019","unstructured":"Muraoka, H. et al. Role of Nampt-Sirt6 axis in renal proximal tubules in extracellular matrix deposition in diabetic nephropathy. Cell Rep. 27, 199-212.e5 (2019).","journal-title":"Cell Rep."},{"key":"18147_CR25","first-page":"2584","volume":"15","author":"MM Murata","year":"2020","unstructured":"Murata, M. M. et al. NAD+ consumption by PARP1 in response to DNA damage triggers metabolic shift critical for damaged cell survival. Mol. Biol. Cell 15, 2584\u20132597 (2020).","journal-title":"Mol. Biol. Cell"},{"key":"18147_CR26","doi-asserted-by":"publisher","first-page":"13503","DOI":"10.1074\/jbc.M300073200","volume":"278","author":"X Zhang","year":"2003","unstructured":"Zhang, X. et al. Structural characterization of a human cytosolic NMN\/NaMN adenylyltransferase and implication in human NAD biosynthesis. J. Biol. Chem. 278, 13503\u201313511 (2003).","journal-title":"J. Biol. Chem."},{"key":"18147_CR27","doi-asserted-by":"publisher","first-page":"12405","DOI":"10.1074\/jbc.M111.304469","volume":"287","author":"T Zang","year":"2012","unstructured":"Zang, T. et al. Regulation of poly(ADP-ribose) polymerase-1-dependent gene expression through promoter-directed recruitment of a nuclear NAD+ synthase. J. Biol. Chem. 287, 12405\u201312416 (2012).","journal-title":"J. Biol. Chem."},{"key":"18147_CR28","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.cmet.2007.09.003","volume":"6","author":"JR Revollo","year":"2007","unstructured":"Revollo, J. R. et al. Nampt\/PBEF\/Visfatin regulates insulin secretion in \u03b2 cells as a systemic NAD biosynthetic enzyme. Cell Metab. 6, 363\u2013375 (2007).","journal-title":"Cell Metab."},{"key":"18147_CR29","first-page":"1321","volume":"33","author":"LR Stein","year":"2014","unstructured":"Stein, L. R. & Imai, S. I. Specific ablation of Nampt in adult neural stem cells recapitulates their functional defects during aging. EMBO J. 33, 1321\u20131340 (2014).","journal-title":"EMBO J."},{"key":"18147_CR30","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.cmet.2011.08.014","volume":"14","author":"J Yoshino","year":"2011","unstructured":"Yoshino, J. et al. Nicotinamide mononucleotide, a key NAD + intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. Cell Metab. 14, 528\u2013536 (2011).","journal-title":"Cell Metab."},{"key":"18147_CR31","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.cmet.2016.09.013","volume":"24","author":"KF Mills","year":"2016","unstructured":"Mills, K. F. et al. Long-term administration of nicotinamide mononucleotide mitigates age-associated physiological decline in mice. Cell Metab. 24, 795\u2013806 (2016).","journal-title":"Cell Metab."},{"key":"18147_CR32","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.nbd.2016.07.018","volume":"95","author":"JH Park","year":"2016","unstructured":"Park, J. H. et al. Nicotinamide mononucleotide inhibits post-ischemic NAD+ degradation and dramatically ameliorates brain damage following global cerebral ischemia. Neurobiol. Dis. 95, 102\u2013110 (2016).","journal-title":"Neurobiol. Dis."},{"key":"18147_CR33","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1177\/0960327115626254","volume":"35","author":"DB Conze","year":"2016","unstructured":"Conze, D. B., Crespo-Barreto, J. & Kruger, C. L. Safety assessment of nicotinamide riboside, a form of vitamin B3. Hum. Exp. Toxicol. 35, 1149\u20131160 (2016).","journal-title":"Hum. Exp. Toxicol."},{"key":"18147_CR34","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1093\/nar\/gkq890","volume":"39","author":"HL Franco","year":"2011","unstructured":"Franco, H. L. et al. Redundant or separate entities?\u2014Roles of Twist1 and Twist2 as molecular switches during gene transcription. Nucleic Acid Res. 39, 1177\u20131186 (2011).","journal-title":"Nucleic Acid Res."},{"key":"18147_CR35","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/S1534-5807(04)00058-9","volume":"6","author":"P Bialek","year":"2004","unstructured":"Bialek, P. et al. A twist code determines the onset of osteoblast differentiation. Dev. Cell 6, 423\u2013435 (2004).","journal-title":"Dev. Cell"},{"key":"18147_CR36","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.cell.2004.06.006","volume":"117","author":"J Yang","year":"2004","unstructured":"Yang, J. et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117, 927\u2013939 (2004).","journal-title":"Cell"},{"issue":"7","key":"18147_CR37","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1369\/jhc.6A7157.2007","volume":"55","author":"Y Kida","year":"2007","unstructured":"Kida, Y. et al. Twist relates to tubular epithelial-mesenchymal transition and interstitial fibrogenesis in the obstructed kidney. J. Histochem. Cytochem. 55(7), 661\u2013673 (2007).","journal-title":"J. Histochem. Cytochem."},{"key":"18147_CR38","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1038\/nm.3902","volume":"21","author":"S Lovisa","year":"2015","unstructured":"Lovisa, S. et al. Epithelialto-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis. Nat. Med. 21, 998\u20131009 (2015).","journal-title":"Nat. Med."},{"key":"18147_CR39","doi-asserted-by":"publisher","first-page":"eaay2793","DOI":"10.1126\/sciadv.aay2793","volume":"6","author":"H Gan","year":"2020","unstructured":"Gan, H. et al. B cell Sirt1 deacetylates histone and non-histone proteins for epigenetic modulation of AID expression and the antibody response. Sci. Adv. 6, eaay2793 (2020).","journal-title":"Sci. Adv."},{"key":"18147_CR40","doi-asserted-by":"publisher","first-page":"4720","DOI":"10.1128\/MCB.06147-11","volume":"31","author":"L Peng","year":"2011","unstructured":"Peng, L. et al. SIRT1 deacetylates the DNA methyltransferase 1 (DNMT1) protein and alters its activities. Mol. Cell Biol. 31, 4720\u20134734 (2011).","journal-title":"Mol. Cell Biol."},{"key":"18147_CR41","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/s41467-017-00498-4","volume":"8","author":"M Liu","year":"2017","unstructured":"Liu, M. et al. Sirt6 deficiency exacerbates podocyte injury and proteinuria through targeting Notch signaling. Nat. Commun. 8, 413 (2017).","journal-title":"Nat. Commun."},{"key":"18147_CR42","first-page":"E187","volume":"24","author":"A Menssen","year":"2012","unstructured":"Menssen, A. et al. The c-MYC oncoprotein, the NAMPT enzyme, the SIRT1-inhibitor DBC1, and the SIRT1 deacetylase form a positive feedback loop. Proc. Natl. Acad. Sci. USA 24, E187\u2013E196 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"18147_CR43","doi-asserted-by":"publisher","first-page":"16018","DOI":"10.1038\/npjsba.2016.18","volume":"18","author":"SI Imai","year":"2016","unstructured":"Imai, S. I. The NAD World 2.0: The importance of the inter-tissue communication mediated by NAMPT\/NAD+\/SIRT1 in mammalian aging and longevity control. NPJ. Syst. Biol. Appl. 18, 16018 (2016).","journal-title":"NPJ. Syst. Biol. Appl."},{"key":"18147_CR44","doi-asserted-by":"publisher","first-page":"C397","DOI":"10.1152\/ajpcell.00438.2010","volume":"300","author":"HM Wyss","year":"2011","unstructured":"Wyss, H. M. et al. Biophysical properties of normal and diseased renal glomeruli. Am. J. Physiol. Cell Physiol. 300, C397-405 (2011).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"18147_CR45","doi-asserted-by":"publisher","first-page":"618898","DOI":"10.3389\/fcell.2020.618898","volume":"2","author":"Z Liu","year":"2021","unstructured":"Liu, Z. et al. Control of podocyte and glomerular capillary wall structure and elasticity by WNK1 kinase. Front Cell Dev. Bio. 2, 618898 (2021).","journal-title":"Front Cell Dev. Bio."},{"key":"18147_CR46","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1681\/ASN.2006060622","volume":"18","author":"H Wu","year":"2007","unstructured":"Wu, H. et al. Depletion of gammadelta T cells exacerbates murine adriamycin nephropathy. J. Am. Soc. Nephrol. 18, 1180\u20131189 (2007).","journal-title":"J. Am. Soc. Nephrol."},{"key":"18147_CR47","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1080\/10715760802657308","volume":"43","author":"L Yang","year":"2009","unstructured":"Yang, L., Zheng, S. & Epstein, P. N. Metallothionein over-expression in podocytes reduces adriamycin nephrotoxicity. Free Radic. Res. 43, 174\u2013182 (2009).","journal-title":"Free Radic. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18147-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18147-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18147-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T02:15:30Z","timestamp":1669342530000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18147-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,12]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["18147"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-18147-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,12]]},"assertion":[{"value":"14 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13712"}}